Popular Trials
CAR T-cell Therapy
CAR T Cell Therapy for Pediatric Solid Cancers
Recruiting1 awardPhase 1
Seattle, Washington
This trial is testing genetically-modified T cells to treat solid tumors in children and young adults. The goal is to evaluate safety and feasibility, and to determine if the cells can kill tumors.
Popular Filters
Trials for Soft Tissue Cancer Patients
CAR T-cell Therapy
Genetically Modified T Cells for Solid Tumors
Recruiting1 awardPhase 1
Toronto, Ontario
This trialtests safety of genetically modified T cells to attack and destroy cancer in ppl with advanced solid tumors (ovarian, synovial sarcoma, esophageal, lung, bladder, liver, and malignant melanoma). Subjects' T cells are modified and given back to them through an IV infusion.
Alkylating agents
Chemotherapy + Radiation for Soft Tissue Sarcoma
Recruiting1 awardPhase 2 & 3
Birmingham, Alabama
This trial is testing whether a new drug called pazopanib, when combined with chemotherapy and radiation, works better for patients with a specific type of soft tissue cancer. Pazopanib helps stop cancer cells from growing, while chemotherapy and radiation kill the cells. The goal is to see if this combination can improve treatment outcomes.
Trials for Cancer Patients
CAR T-cell Therapy
Gene-Modified T Cells for Advanced Cancers
Recruiting1 awardPhase 1 & 2
Buffalo, New York
This trial is testing the side effects and best dose of gene-modified T cells, given with or without decitabine, to treat patients with malignancies expressing cancer-testis antigens 1 (NY-ESO-1) gene that have spread to other places in the body (advanced).
Alkylating agents
Chemotherapy + Radiation for Soft Tissue Sarcoma
Recruiting1 awardPhase 2 & 3
Birmingham, Alabama
This trial is testing whether a new drug called pazopanib, when combined with chemotherapy and radiation, works better for patients with a specific type of soft tissue cancer. Pazopanib helps stop cancer cells from growing, while chemotherapy and radiation kill the cells. The goal is to see if this combination can improve treatment outcomes.
CAR T-cell Therapy
CAR T Cell Therapy for Pediatric Cancer
Recruiting1 awardPhase 1
Seattle, Washington
This trial tests a new treatment for children and young adults with hard-to-treat solid tumors. It uses the patient's own immune cells, modified to better attack cancer cells. The study aims to see if this approach is safe and effective. This type of therapy has shown remarkable results in young patients with certain types of blood cancers.
Checkpoint Inhibitor
Pre-Surgery Nivolumab + BO-112 for Soft Tissue Sarcoma
Recruiting1 awardPhase 1
Los Angeles, California
This trial is testing the side effects of a combination of two drugs, one of which helps the body's immune system attack cancer cells, before surgery in patients with a type of cancer that can be removed surgically.
Trials for HLA-A Positive Patients
CAR T-cell Therapy
Genetically Modified T Cells for Solid Tumors
Recruiting1 awardPhase 1
Toronto, Ontario
This trialtests safety of genetically modified T cells to attack and destroy cancer in ppl with advanced solid tumors (ovarian, synovial sarcoma, esophageal, lung, bladder, liver, and malignant melanoma). Subjects' T cells are modified and given back to them through an IV infusion.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.